For: |
Qi J, Zhu YQ, Huang MF, Yang D. Hypermethylation of CpG island in O6-methylguanine-DNA methyltransferase gene was associated with |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i13/2022.htm |
Number | Citing Articles |
1 |
Chun Y. Wong, Jorge Martinez, Jian Zhao, Hani Al-Salami, Crispin R. Dass. Development of orally administered insulin-loaded polymeric-oligonucleotide nanoparticles: statistical optimization and physicochemical characterization. Drug Development and Industrial Pharmacy 2020; 46(8): 1238 doi: 10.1080/03639045.2020.1788061
|
2 |
Marta Brell, Javier Ibáñez, Avelina Tortosa. O6-Methylguanine-DNA methyltransferase protein expression by immunohistochemistry in brain and non-brain systemic tumours: systematic review and meta-analysis of correlation with methylation-specific polymerase chain reaction. BMC Cancer 2011; 11(1) doi: 10.1186/1471-2407-11-35
|
3 |
Jian Qi, You-Qing Zhu, Jun Luo, Wen-Hui Tao. Hypermethylation and expression regulation of secreted frizzled-related protein genes in colorectal tumor. World Journal of Gastroenterology 2006; 12(44): 7113-7117 doi: 10.3748/wjg.v12.i44.7113
|
4 |
Sameer Mirza, Gayatri Sharma, Pranav Pandya, Ranju Ralhan. Demethylating agent 5-aza-2-deoxycytidine enhances susceptibility of breast cancer cells to anticancer agents. Molecular and Cellular Biochemistry 2010; 342(1-2): 101 doi: 10.1007/s11010-010-0473-y
|
5 |
Gayatri Sharma, Sameer Mirza, Rajinder Parshad, Anurag Srivastava, Siddartha Datta Gupta, Pranav Pandya, Ranju Ralhan. Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients. Life Sciences 2010; 87(3-4): 83 doi: 10.1016/j.lfs.2010.05.001
|
6 |
Shee-Ping Chen, Sheng-Chun Chiu, Chang-Chieh Wu, Shinn-Zong Lin, Jung-Cheng Kang, Yi-Lin Chen, Po-Cheng Lin, Cheng-Yoong Pang, Horng-Jyh Harn. The Association of Methylation in the Promoter of APC and MGMT and the Prognosis of Taiwanese CRC Patients. Genetic Testing and Molecular Biomarkers 2009; 13(1): 67 doi: 10.1089/gtmb.2008.0045
|
7 |
Chi‐Chou Huang, Wen‐Pin Chien, Ruey‐Hong Wong, Ya‐Wen Cheng, Meng‐Cheng Chen, Huei Lee. NAT2 fast acetylator genotype and MGMT promoter methylation may contribute to gender difference in K‐RAS mutation occurrence in Taiwanese colorectal cancer. Environmental and Molecular Mutagenesis 2009; 50(2): 127 doi: 10.1002/em.20444
|
8 |
Stephan Stern, Scott McNeil, Anil Patri, Marina Dobrovolskaia. Nanotechnology for Cancer Therapy. 2006; : 105 doi: 10.1201/9781420006636.ch7
|
9 |
Alfonso Dueñas-González, Marcela Lizano, Myrna Candelaria, Lucely Cetina, Claudia Arce, Eduardo Cervera. Epigenetics of cervical cancer. An overview and therapeutic perspectives. Molecular Cancer 2005; 4(1) doi: 10.1186/1476-4598-4-38
|
10 |
O. OZALP YUREGIR, E. YURTCU, E. KIZILKILIC, N. E. KOCER, H. OZDOGU, F. I. SAHIN. Detecting methylation patterns of p16, MGMT, DAPK and E‐cadherin genes in multiple myeloma patients. International Journal of Laboratory Hematology 2010; 32(2): 142 doi: 10.1111/j.1751-553X.2009.01146.x
|
11 |
Isabela Angeli de Lima, Najeh Maissar Khalil, Tania Toyomi Tominaga, Anna Lechanteur, Bruno Sarmento, Rubiana Mara Mainardes. Mucoadhesive chitosan-coated PLGA nanoparticles for oral delivery of ferulic acid. Artificial Cells, Nanomedicine, and Biotechnology 2018; 46(sup2): 993 doi: 10.1080/21691401.2018.1477788
|
12 |
Diego M Marzese, Dave SB Hoon. Emerging technologies for studying DNA methylation for the molecular diagnosis of cancer. Expert Review of Molecular Diagnostics 2015; 15(5): 647 doi: 10.1586/14737159.2015.1027194
|
13 |
Xiahui Liu, Yingying Zhang, Dongmei Ma, Hao Tang, Liang Tan, Qingji Xie, Shouzhuo Yao. Biocompatible multi-walled carbon nanotube-chitosan–folic acid nanoparticle hybrids as GFP gene delivery materials. Colloids and Surfaces B: Biointerfaces 2013; 111: 224 doi: 10.1016/j.colsurfb.2013.06.010
|
14 |
Pooneh Mokarram, Mehrdad Asghari Estiar, Hassan Ashktorab. Epigenetics Territory and Cancer. 2015; : 373 doi: 10.1007/978-94-017-9639-2_13
|
15 |
Sally M. Shalaby, Amal S. El-Shal, Lobna A. Abdelaziz, Eman Abd-Elbary, Mostafa M. Khairy. Promoter methylation and expression of DNA repair genes MGMT and ERCC1 in tissue and blood of rectal cancer patients. Gene 2018; 644: 66 doi: 10.1016/j.gene.2017.10.056
|
16 |
|
17 |
Suphiya Parveen, Sanjeeb K. Sahoo. Polymeric nanoparticles for cancer therapy. Journal of Drug Targeting 2008; 16(2): 108 doi: 10.1080/10611860701794353
|
18 |
Paul Schlinkert, Eudald Casals, Matthew Boyles, Ulrike Tischler, Eva Hornig, Ngoc Tran, Jiayuan Zhao, Martin Himly, Michael Riediker, Gertie Janneke Oostingh, Victor Puntes, Albert Duschl. The oxidative potential of differently charged silver and gold nanoparticles on three human lung epithelial cell types. Journal of Nanobiotechnology 2015; 13(1) doi: 10.1186/s12951-014-0062-4
|
19 |
Alessio Amatu, Andrea Sartore-Bianchi, Catia Moutinho, Alessandro Belotti, Katia Bencardino, Giuseppe Chirico, Andrea Cassingena, Francesca Rusconi, Anna Esposito, Michele Nichelatti, Manel Esteller, Salvatore Siena. Promoter CpG Island Hypermethylation of the DNA Repair Enzyme MGMT Predicts Clinical Response to Dacarbazine in a Phase II Study for Metastatic Colorectal Cancer. Clinical Cancer Research 2013; 19(8): 2265 doi: 10.1158/1078-0432.CCR-12-3518
|
20 |
Jaime Antonio Oliver, Raúl Ortiz, Consolación Melguizo, Pablo Juan Álvarez, Jaime Gómez-Millán, Jose Prados. Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma. BMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-511
|
21 |
Sergio Alonso, Yuichi Dai, Kentaro Yamashita, Shina Horiuchi, Tomoko Dai, Akihiro Matsunaga, Rosa Sánchez-Muñoz, Cristina Bilbao-Sieyro, Juan Carlos Díaz-Chico, Andrei V. Chernov, Alex Y. Strongin, Manuel Perucho. Methylation ofMGMTandADAMTS14in normal colon mucosa: biomarkers of a field defect for cancerization preferentially targeting elder African-Americans. Oncotarget 2015; 6(5): 3420 doi: 10.18632/oncotarget.2852
|
22 |
Zhipeng Chen, Lu Xiao, Wen Liu, Dan Liu, Yan-Yu Xiao, Jun Chen, Xiao Liu, Wei-Dong Li, Wei Li, Bao-Chang Cai. Novel materials which possess the ability to target liver cells. Expert Opinion on Drug Delivery 2012; 9(6): 649 doi: 10.1517/17425247.2012.679261
|
23 |
Chen-guo Zheng, Chun Jin, Le-chi Ye, Nian-zhao Chen, Zong-Jing Chen. Clinicopathological significance and potential drug target of O6-methylguanine-DNA methyltransferase in colorectal cancer: a meta-analysis. Tumor Biology 2015; 36(8): 5839 doi: 10.1007/s13277-015-3254-0
|
24 |
F. Bishehsari, M. Mahdavinia, R. Malekzadeh, F. Verginelli, T. Catalano, M. Sotoudeh, V. Bazan, V. Agnese, D.L. Esposito, L. De Lellis, D. Semeraro, G. Colucci, M. Hormazdi, N. Rakhshani, A. Cama, M. Piantelli, S. Iacobelli, A. Russo, R. Mariani-Costantini. Patterns of K-ras mutation in colorectal carcinomas from Iran and Italy (a Gruppo Oncologico dell'Italia Meridionale study): influence of microsatellite instability status and country of origin. Annals of Oncology 2006; 17: vii91 doi: 10.1093/annonc/mdl959
|
25 |
Lifeng Qi, Zirong Xu. In vivo antitumor activity of chitosan nanoparticles. Bioorganic & Medicinal Chemistry Letters 2006; 16(16): 4243 doi: 10.1016/j.bmcl.2006.05.078
|
26 |
Khalid A. Alamry, Mahmoud A. Hussein, Youssef O. Al-Ghamdi, Tamer S. Saleh, Abdullah M. Asiri, Alawi M. Alhebshi, George William Weaver. Potential anti-cancer performance of chitosan-based β-ketosulfone derivatives. Cogent Chemistry 2018; 4(1): 1559435 doi: 10.1080/23312009.2018.1559435
|
27 |
Vanessa Deschoolmeester, Marc Baay, Pol Specenier, Filip Lardon, Jan B. Vermorken. A Review of the Most Promising Biomarkers in Colorectal Cancer: One Step Closer to Targeted Therapy. The Oncologist 2010; 15(7): 699 doi: 10.1634/theoncologist.2010-0025
|
28 |
Shee-Ping Chen, Sheng-Chun Chiu, Chang-Chieh Wu, Shinn-Zong Lin, Jung-Cheng Kang, Yi-Lin Chen, Po-Cheng Lin, Cheng-Yoong Pang, Horng-Jyh Harn. The Association of Methylation in the Promoter ofAPCandMGMTand the Prognosis of Taiwanese CRC Patients. Genetic Testing 2009; 0(0): 090108090224061 doi: 10.1089/gte.2008.0045
|